Human Genome Sciences Inc. Seeks FDA Approval of Anthrax Drug ABthrax

Human Genome Sciences Inc. Seeks FDA Approval of Anthrax Drug ABthrax

HGSI asks for FDA approval of anthrax drug ABthraxAssociated Press, 05.21.09, 08:00 AM EDT Human Genome Sciences Inc. [link to board of directors] said Thursday it asked the Food and Drug Administration to approve ABthrax, a drug it is developing to treat inhaled anthrax. Human Genome Sciences submitted a Biologics License Application for ABthrax, or raxibacumab. The company is developing the drug for emergency use, such as a bioterrorist attack. Human Genome Sciences delivered 20,000 doses of the drug to the U.S. Strategic National Stockpile in the first quarter.http://www.forbes.com/feeds/ap/2009/05/21/ap6450866.html

Leave a Reply

Be the First to Comment!

Notify of
avatar
wpDiscuz